gms | German Medical Science

68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
7. Joint Meeting mit der Britischen Gesellschaft für Neurochirurgie (SBNS)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

14. - 17. Mai 2017, Magdeburg

Does Wound Dehiscence in Cranioplasty with Customized Implants always warrant explantation?

Meeting Abstract

  • Dorothee Mielke - Universitätsmedizin Göttingen, Klinik und Poliklinik für Neurochirurgie, Göttingen, Deutschland
  • Thomas Engstrand - Stockholm Craniofacial Centre, Department of Molecular Medicine and Surgery, Plastic Surgery Section, Solna, Sweden
  • Ulrik Birgersson - Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Sweden
  • Veit Rohde - Universitätsmedizin Göttingen, Klinik für Neurochirurgie, Göttingen, Deutschland
  • Lars Kihlström - Department of Clinical Neuroscience, Neurosurgical Section, Karolinska University Hospital and Karolinska Institute, Solna, Sweden

Deutsche Gesellschaft für Neurochirurgie. Society of British Neurological Surgeons. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS). Magdeburg, 14.-17.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocMi.07.05

doi: 10.3205/17dgnc406, urn:nbn:de:0183-17dgnc4067

Veröffentlicht: 9. Juni 2017

© 2017 Mielke et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Cranioplasty using autologous bone grafts or alloplastic implants are associated with risks of bone resorption, infection and/or protrusion through the skin. Wound dehiscence with implant exposure and signs of infection usually calls for implant removal in order to avoid serious complications.

Methods: In a cohort of 69 patients having received a custom made ceramic implant a total of 6 wound dehicences with implant exposure were encountered. The wound dehiscences occurred in 4 female and 2 male patients out of which half had been treated initially for either a traumatic brain incident or tumor growth. 4 patients had suffered from previous implant failures due to infection or extensive postoperative oedema. In all cases the wound opening occurred through the incision located over the implant exposing the implant surface. In these patients wound edges were revised and superficial layers of the exposed ceramic surface of the implant were trimmed using a scalpel in order to mechanically remove any potential contaminant. Thereafter, the area was treated with antibiotics and, due to often very fragile and thin patient skin, the wound openings were closed with various skin flap techniques.

Results: Out of the 6 patients who underwent wound revision 5 recovered well and followed an expected post-operative course. Only 1 patient suffered from a persistent wound dehiscence with multiple wound infections which lead to the implant being removed six months post-surgery.

Conclusion: In case of a wound dehiscence the selected course of action might not necessarily be explantation. The custom made design and structure of an implant may enable either partial removal or trimming of an implant without the need to remove the entire implant.